Kirkland & Ellis advised Bansk Group, a private investment firm focused on building distinctive consumer brands, on the successful close of a continuation fund to expand its partnership with Arcadia Consumer Healthcare, a recognized leader and one of the fastest growing platforms in the consumer healthcare market for over-the-counter medicines and premium vitamins and nutritional supplements. The transaction was co-led by Coller Capital and Ares Secondaries Fund, with additional support from investment funds managed by BlackRock, Churchill, Dextra Partners and Future Standard, among other investors. Since Bansk’s initial investment in 2021, Arcadia has implemented several organic growth initiatives and successfully executed two major acquisitions. With this infusion of capital, the Company is well-positioned to accelerate organic and inorganic growth, further enhancing its portfolio and expanding its reach and impact in the consumer healthcare sector. Read the transaction release The Kirkland team included investment funds lawyers Eric Fischer, Andrew Wright, Ray Xu, Semhar Woldai, Josh Rabinovits, Alex Weinman, Monique Groen, Joseph Salvatore, Ashley Lee, Jack Baumruk, Brian Ferrell, Geraghty Alch, Margaret O’Connor, Albert Yakobashvili and Michael Shields; corporate lawyers Constantine Skarvelis, Oliver Yee and Matthew Brenner; tax lawyers David Grenker, Tim Campany and Claire Oxford; investment funds ERISA lawyer Christine Matott; investment funds regulatory lawyers Scott Moehrke and Peter Gauss; financial services regulatory lawyers Albert Weatherill and Stefan Nesic; and debt finance lawyers Kathryn Leonard, Aditi Iyer, Tony Tsai, Raghav Gupta, Adam Brandy, Ana Rijal and Clare Azzopardi.